Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Apr 06, 2007 1:09am
306 Views
Post# 12560724

RE: $60

RE: $60I figured you'd be back tonight after your gibberish today. That's why I titled the post "$60". Here's your challenge, InTheKnow0. Stop posting all the anti-this and anti-that. Put some thought and effort into it. I've said $60 for 3 years and I've posted the reasons for it, time after time after time, some would say ad nauseum. You put up your number and the reasons for it with the clarity that I have and then we can talk. It's going to take some time for you get a handle on the science but you can do it. I can tell from your posts that you haven't done that yet. Don't bother with the same old "it's not even in clinical trials" nonsense, either. Discuss the science. Discuss the IP. The market it plays into and the expiring statin patents. The exclusivity. The methods of discovery. Related research. Timelines for IND, Phase I, Phase II. Discuss the relevance of Esperion, their work and ultimate fate. Discuss the players. Discuss the many indications that may be affected. Why does it work? What is the assaying technology and why is it so fundamental to the success of RVX? Why is the assaying technology a major reason for a quick sale of RVX? Why might NexVas for acute care force an even quicker sale? What's a scaffold? How does CETP relate to NexVas? Why is there a reasonable expectation of a sale long before even Phase II starts? Why will the stock market have no say in the ultimate sale price of RVX? That's a partial list. When you can discuss these things like I can then you can discuss $60 with me. Until them we'll just let this forum judge what you know and don't know. Did I forget to put "arrogant" in my list of qualities? I can't imagine how I forgot that, given how proud I am of it. Stick "combative" in there, too. And "not intimidated". And "confident". And "humble". I'm sure glad I've got my homework done. I wouldn't want to be just starting like you are. And forget the conspiracy stuff. Five of the top seven cardiologists in the world are working with RVX. They joined up after seeing the goods. Nobody will buy the conspiracy crap, InTheKnowNot4ButNothing.
Bullboard Posts